K
59
2
SHW
73
8
VMC
62
5
TGNA
58
2
CCI
33
2
SWKS
55
5
TSN
40
-2
CA
47
9
MS
72
-4
COF
63
3
DE
68
5
UPS
64
4
UAL
85
3
ACN
50
-2
TROW
61
5
AIZ
82
2
KLAC
56
9
MDLZ
38
2
WDC
50
3
KSS
46
12
K
59
2
SHW
73
8
VMC
62
5
TGNA
58
2
CCI
33
2
SWKS
55
5
TSN
40
-2
CA
47
9
MS
72
-4
COF
63
3
DE
68
5
UPS
64
4
UAL
85
3
ACN
50
-2
TROW
61
5
AIZ
82
2
KLAC
56
9
MDLZ
38
2
WDC
50
3
KSS
46
12
Financhill
Back

Range Cancer Therapeutics ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison

Sell
49

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Buy
52

FTXH
First Trust Nasdaq Pharmaceuticals ETF

Last Price:
28.00
Seasonality Move:
4.46%
Sell
49
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $13.79. The Score for CNCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Buy

Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.29. The Score for FTXH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • FTXH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $13.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

FTXH Stock Price Chart

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

  • The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 40.74 Sell
Chaikin Money Flow: -17976 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.81 - 15.43) Sell
Bollinger Bands (100): (14.1 - 15.46) Sell

FTXH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 51.91 Buy
Chaikin Money Flow: -7899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.63 - 28.73) Buy
Bollinger Bands (100): (27.98 - 29.14) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.55 Buy
20-day SMA: 14.53 Sell
50-day SMA: 14.82 Sell
200-day SMA: 15.04 Sell
8-day EMA: 13.77 Buy
20-day EMA: 14.27 Sell
50-day EMA: 14.62 Sell
200-day EMA: 14.55 Sell

FTXH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.61 Buy
20-day SMA: 28.17 Buy
50-day SMA: 28.48 Sell
200-day SMA: 27.85 Buy
8-day EMA: 27.91 Buy
20-day EMA: 28.09 Buy
50-day EMA: 28.33 Sell
200-day EMA: 27.88 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Trust Nasdaq Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):